Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00000774
What this trial is testing

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 156
Early research (Phase 1)WithdrawnNCT02386150
What this trial is testing

ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ - 3-Dose Primary Series With Boost

Who this might be right for
Ricin Poisoning
U.S. Army Medical Research and Development Command
Post-approval studies (Phase 4)Looking for participantsNCT07668271
What this trial is testing

Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

Who this might be right for
Infection by Human Papilloma Virus
Xiamen Innovax Biotech Co., Ltd 720
Not applicableStudy completedNCT02567721
What this trial is testing

Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)

Who this might be right for
Influenza
GlaxoSmithKline 11,530
Early research (Phase 1)Study completedNCT00089908
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 28
Large-scale testing (Phase 3)Study completedNCT02214225
What this trial is testing

Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.

Who this might be right for
Influenza, Human
Seqirus 3,484
Testing effectiveness (Phase 2)Study completedNCT05052697
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

Who this might be right for
Influenza, Human
Pfizer 1,158
Post-approval studies (Phase 4)Study completedNCT01196026
What this trial is testing

Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™

Who this might be right for
Influenza
GlaxoSmithKline 162
Testing effectiveness (Phase 2)Study completedNCT01625689
What this trial is testing

Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine

Who this might be right for
Influenza
PATH Vaccine Solutions 309
Early research (Phase 1)Study completedNCT02873260
What this trial is testing

Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)UnknownNCT00004025
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Genzyme, a Sanofi Company 36
Not applicableStudy completedNCT05568979
What this trial is testing

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

Who this might be right for
Influenza (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 1,001
Testing effectiveness (Phase 2)Study completedNCT00869713
What this trial is testing

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated

Who this might be right for
Rift Valley Fever
U.S. Army Medical Research and Development Command 98
Large-scale testing (Phase 3)Study completedNCT00835380
What this trial is testing

2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)

Who this might be right for
Hepatitis A Virus Infection
Merck Sharp & Dohme LLC 80
Testing effectiveness (Phase 2)Study completedNCT01511250
What this trial is testing

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Who this might be right for
Healthy
Takeda 360
Testing effectiveness (Phase 2)Study completedNCT02199691
What this trial is testing

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,715
Early research (Phase 1)WithdrawnNCT04041674
What this trial is testing

Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult Participants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT01097096
What this trial is testing

Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 177
Post-approval studies (Phase 4)UnknownNCT01967368
What this trial is testing

Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults

Who this might be right for
Influenza, Human
The University of Hong Kong 100
Post-approval studies (Phase 4)Study completedNCT01641991
What this trial is testing

Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 328
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation